Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Ara-C

Ara-C

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Ara-C

19 trials tracked of Ara-C: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 22 citations.

19Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 2 Phase 2 15 Other / NA 1
  1. Phase 4 Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL) Completed · 22 cited
  2. Phase 3 Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients Completed
  3. Phase 3 UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy Completed
  4. Phase 2 T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts Completed
  5. Phase 2 High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML Completed
  6. Phase 2 Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies Completed
Show 13 more trials
  1. Phase 2 Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma Completed
  2. Phase 2 RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia Completed
  3. Phase 2 Selinexor (KPT-330) in Older Patients With Relapsed AML Completed
  4. Phase 2 Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma Completed
  5. Phase 2 Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia Completed
  6. Phase 2 Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage Completed
  7. Phase 2 Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients Completed
  8. Phase 2 Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) Completed
  9. Phase 2 Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients Completed
  10. Phase 2 Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) Completed
  11. Phase 2 Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma Completed
  12. Phase 2 Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). Completed
  13. N/A Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease Completed

Showing the 19 most-cited and recently-updated of 19 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.